好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Updates on Neuro Day: An Innovative 好色先生al Intervention Connecting Patients and Medical Trainees
好色先生, Research, and Methodology
S33 - Innovations in Medical 好色先生 (1:36 PM-1:48 PM)
004
To provide early clinical exposure to neurologic diseases, create authentic patient-teacher experiences, and increase interest in studying neurology. 
Neurophobia is a barrier for medical trainees seeking out a future career in neurology. Using innovating strategies to strengthen interactions between patients and medical students may help to dispel misinformation about neurologic treatment options and patient outcomes and increase interest in pursuing a career in neurology. 
In this updated iteration of Neuro Day, a mock patient rounds was instituted for first-year medical students. Small groups of medical students rotated from room to room to complete ten different stations. Eight stations consisted of patients with real neurologic diseases in which the patients shared their personal experience with their disease followed by a neurology physician discussing the pathophysiology and highlighting clinically relevant exam findings. The remaining two stations allowed medical students to practice neurologic examination techniques. Students were surveyed before and after Neuro Day. Paired T-test was used for statistical analysis and thematic analysis was used for free response. 
Following Neuro Day, there were several statistically significant results, including: 1) increased interest in pursuing neurology for residency (p=0.017); 2) improved perception of patient outcomes (p=0.0001) and treatment options (p=6.4*10-12); 3) increased value placed on case discussions (p=0.027), clinical skills demonstrations (p=0.027), and patient encounters (p=1.16*10-6) to teach neurology; 4) increased interest in studying neurology (p=0.003), increased comfort level with performing a neurologic exam (p=1.15*10-6), and increased interest in pursuing neurology as a career (p=0.023). Thematic analysis revealed Neuro Day helped to reinforce course content, improved resiliency and burnout, and was recommended by medical students to be adapted for other medical school courses. 
This updated version of Neuro Day was well-received by medical students and continues to be a feasible teaching paradigm to increase interest in neurology. 
Authors/Disclosures
Jessica Frey, MD (West Virginia University)
PRESENTER 		The institution of Dr. Frey has received research support from Tourette Association of America.
Brandon C. Neeley, MD (Vanderbilt University Medical Center) Dr. Neeley has nothing to disclose.
Gabriella P. Casinelli, MD (WVU) Dr. Casinelli has nothing to disclose.
Benjamin A. Paserba, MD (West Virginia University) Dr. Paserba has nothing to disclose.
Delanie Talkington Delanie Talkington has nothing to disclose.
Patrick Sheehan Patrick Sheehan has nothing to disclose.
Bruce Palmer (West Virginia University) No disclosure on file
James Lewis (West Virginia University) No disclosure on file
Amelia K. Adcock, MD (WVU School of Medicine, Dept. of Neurology) The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Eric J. Seachrist, MD (West Virginia University) Dr. Seachrist has stock in Medtronic. Dr. Seachrist has stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with 好色先生 that is relevant to AAN interests or activities.
Ann Murray, MD (West Virginia Department of Neurology) Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Gauri V. Pawar, MD, FAAN (West Virginia University) Dr. Pawar has nothing to disclose.